Clasado Biosciences, a global leader in the development of scientifically proven prebiotic ingredients and product solutions for gut health, has appointed speciality ingredient distributor ACI Group as its distribution partner for Bimuno® GOS across the UK and Ireland.
The agreement strengthens the availability of Bimuno GOS, the most comprehensively studied galactooligosaccharide (GOS) prebiotic available to brands and formulators for adult nutrition, in one of Europe’s most dynamic nutraceutical markets.
A speciality ingredient distributor serving the UK’s food, nutraceutical, pharmaceutical, pet nutrition and industrial sectors, ACI Group has built its nutraceutical business around partnering with scientifically credible manufacturers and helping customers develop differentiated, evidence-based products. That philosophy aligns closely with Clasado’s own science-led positioning.
The timing reflects a category in clear growth. According to intelligence firm FMCG Gurus, the UK digestive health supplement market is projected to reach a value of US$846.3m by 2033, with almost half of UK supplement users looking to support digestive health. This highlights sustained demand for clinically substantiated gut health solutions, which is precisely where Bimuno GOS is designed to deliver.
Marcelo Durante, VP of Sales & Marketing at Clasado, commented: “ACI Group is one of the most knowledgeable distributors for the health and nutrition market, and appointing them as our partner for Bimuno GOS is a great match. This partnership brings together our world-leading gut microbiome science with ACI’s commercial and market expertise. It’s a combination that will help brands and formulators here create genuinely differentiated, evidence-based products that make a real difference for consumers.”
Gareth Clark, Sales Director at ACI Group, said: “We are delighted to partner with Clasado and add Bimuno GOS to our premium nutraceutical portfolio. The market continues to move towards clinically substantiated, science-led ingredients, and Bimuno GOS is backed by an exceptional body of clinical evidence of more than 135 scientific publications, including over 25 clinical trials.
“We see significant opportunities across gut health, active nutrition, women’s health and healthy ageing, and we’re excited to work with Clasado to help brands and formulators bring innovative new products to the UK and Irish markets.”
Annika Malmros, Director of Business Development at Clasado, added: “It’s partnerships like this that turn strong science into products people actually feel the benefit of. Also important, is that despite fibre’s well-established benefits, the average UK adult consumes around 15-16g per day, against the British Nutrition Federation recommendation of 30g. This persistent gap is something that a prebiotic ingredient like Bimuno GOS is ideally placed to help close in addition to the health benefits it offers.”
The partnership will focus on key areas within human and pet health and nutrition driven by consumer demand, such as gut health, active nutrition, healthy ageing. Bimuno GOS offers brands and formulators notable versatility. With a low effective daily dose and availability in both powder and syrup formats, it remains stable across a wide range of pH levels and temperatures, making it suitable for applications from supplements and functional foods to beverages and pet nutrition.
To learn more about ACI Group and its activities, please visit https://acigroup.biz/.
